Antianginal treatment and quality of life in patients with chronic coronary heart disease

Antianginal treatment and quality of life in patients with chronic coronary heart disease

Aim. To assess the effects of various antianginal nitrate therapy variants on quality of life (QoL) in patients with chronic coronary heart disease (CHD). Material and methods. In total, 259 patients were examined: 153 males (59,1 %) and 106 females (40,9 %); mean age 62,6±3,4 years. All participant...

Full description

Saved in:

Bibliographic Details
Main Authors:	B. I. Geltser, E. V. Solyanik, E. Ya. Yakukhnaya, Yu. Yu. Karpinskaya, E. L. Shuvalova
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 1970-01-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	stable effort angina nitrates quality of life
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1472
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PSYCHOMETRIC VISUAL ANALOGUE SCALE IN ASSESSMENT OF THE STABLE ANGINA SEVERITY AND EFFICACY OF ANTIANGINAL THERAPY
by: E. V. Solyanik
Published: (2016-01-01)

Optimized antianginal therapy: a randomized, comparative study of long-acting isosorbide-5-mononitrate and isosorbide dinitrate in patients with coronary heart disease and stable effort angina
by: Yu. E. Semenova, et al.
Published: (2005-08-01)

Antianginal effectiveness and tolerability of ivabradine in patients with stable angina: CONTROL-2 Study results
by: Yu. A. Karpov, et al.
Published: (1970-01-01)

ASSESSMENT OF ADHERENCE TO TREATMENT AND FACTORS AFFECTING IT IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE DURING THERAPY WITH NICORANDIL
by: S. Yu. Martsevich, et al.
Published: (2017-12-01)

Specific of treating elderly patients with coronary heart disease and alexithymia
by: E. S. Burlova, et al.
Published: (2004-04-01)

Isosorbide dinitrate inhaler and quality of life in stable angina patients
by: A. A. Kirichenko, et al.
Published: (2005-06-01)

AFFECTIVE DISORDERS AND QUALITY OF LIFE IN PATIENTS WITH CORONARY HEART DISEASE ACCORDING TO PSYCHOMETRIC TESTS DATA
by: S. Yu. Mukhtarenko, et al.
Published: (2018-11-01)

Clinico-angiographic parallels in patients with coronary atherosclerosis risk factors
by: A. I. Koryakov
Published: (2006-06-01)

Self-care as the Basis of the Mobile Application for Patients with Chronic Coronary Syndromes
by: A. I. Laskova, et al.
Published: (2022-07-01)

CARDIOPROTECTION POTENTIAL IN CORONARY HEART DISEASE TREATMENT
by: N. A. Shostak, et al.
Published: (2009-12-01)

Systemic enzyme therapy and clinical and hemorheological parameters in coronary heart disease patients with effort angina
by: A. Yu. Konyakhin, et al.
Published: (2005-06-01)

THE STUDY OF LIFE QUALITY IN INTERVENTIONAL AND CONSERVATIVE TREATMENTS OF THE PATIENTS WITH STABLE ANGINA AT DELAYED OBSERVATIONS
by: D. V. Dedov, et al.
Published: (2014-10-01)

Basic diagnostic criterions for effort angina on coronary angiography dates
by: A. I. Koryakov
Published: (2005-12-01)

Importance of early diagnostics of chronic obstructive pulmonary disease in patients with coronary heart disease
by: A. N. Kuznetsov, et al.
Published: (2011-06-01)

TREATMENT ADHERENCE AND QUALITY OF LIFE OF PATIENTS WITH STABLE ISCHEMIC HEART DISEASE IN TREATMENT WITH NICORANDIL: INTERRELATION AND INTERACTION (ACCORDING TO THE RESULTS OF THE OBSERVATIONAL STUDY NIKEA)
by: S. Yu. Martsevich, et al.
Published: (2018-07-01)

ASSESSMENT OF ANTIISCHEMIC AND ANTIANGINAL EFFECTS OF NICORANDIL BY TREADMILL TEST, UNDER THE FRAMEWORK OF KVAZAR STUDY
by: V. P. Voronina, et al.
Published: (2017-03-01)

OBSERVATIONAL MULTICENTER TRIAL OF NICORANDIL USE IN STABLE CORONARY HEART DISEASE HIGH RISK PATIENTS (NIKEA): DESIGN AND FIRST RESULTS
by: S. Yu. Martsevich, et al.
Published: (2017-10-01)

THE ASSESSMENT OF NICORANDIL EFFECT ON THE QUALITY OF LIFE IN PATIENTS WITH STABLE ANGINA IN THE "KVAZAR" STUDY
by: S. Yu. Martsevich, et al.
Published: (2017-01-01)

Comparison of antianginal and antiischemic efficacy of cytoprotectors, nitrates, and beta-blockers during monotherapy and combined therapy in patients with effort angina and silent myocardial ischemia episodes
by: S. N. Vaslyaeva, et al.
Published: (2004-06-01)

The efficacy and safety of coronary sinus reducer in refractory angina: a systematic review and meta-analysis
by: Ahmed Elshahat, et al.
Published: (2025-07-01)

Heart rate-reducing agents ivabradine and beta-adrenoblockers in the management of patients with stable effort angina
by: Z. M. Galeeva, et al.
Published: (2011-02-01)

MODERN HIGH-SENSITIVE TROPONIN DIAGNOSTIC METHODS IN ASSESSMENT OF MYOCARDIAL ISCHEMIA AND PROGNOSTICAL VALUE FOR CHRONIC CORONARY HEART DISEASE
by: L. V. Kremneva, et al.
Published: (2017-03-01)

Mildronate in cardiology practice – current evidence, ongoing research, and future perspectives
by: V. P. Mikhin, et al.
Published: (2012-02-01)

LEVELS OF INTERLEUKINS AND MELATONIN IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: M. A. Shalenkova, et al.
Published: (2014-11-01)

Comparative analysis of adherence to treatment in patients with various forms of coronary heart disease
by: A. I. Pavlov, et al.
Published: (2023-04-01)

New potential of Trimetazidine MB for coronary heart disease treatment in the real-world clinical practice: results of the Russian multi-centre randomised study PERSPECTIVE (Part II)
by: M. G. Bubnova, et al.
Published: (2011-12-01)

Secondary Prevention and Quality of Life of Patients with Stable Coronary Heart Disease
by: E. D. Zharkova, et al.
Published: (2023-05-01)

IMMUNO-CORRECTING THERAPY AND INCREASED NITRATE EFFECTIVENESS IN ANGINA TREATMENT
by: V. V. Anikin, et al.
Published: (2010-10-01)

Possibilities of Combination of Beta-blockers and Ivabradine in Patients with Stable Angina Pectoris
by: V. V. Kashtalap, et al.
Published: (2019-11-01)

THE DYNAMICS OF LIFE QUALITY PARAMETERS WITH NICORANDIL USAGE IN STABLE CORONARY HEART DISEASE PATIENTS (RESULTS OF THE OBSERVATION STUDY “NIKEA”)
by: S. Yu. Martsevich, et al.
Published: (2017-12-01)

TRIMETAZIDINE THERAPY INFLUENCE ON HEART RATE VARIABILITY IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE
by: M. V. Novikova, et al.
Published: (2014-10-01)

Trimetazidine in coronary heart disease patients: mechanism of action and controlled trials’ results
by: L. V. Kremneva, et al.
Published: (2005-04-01)

Antiischemic effects of metoprolol and the risk of carbohydrate metabolism disturbances in angina patients
by: E. V. Bochkareva, et al.
Published: (2012-12-01)

COMPARISON OF CLINICAL EFFICACY OF ORIGINAL BISOPROLOL AND ITS GENERIC DRUG IN PATIENTS WITH STABLE ANGINA AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: N. Yu. Grigorieva, et al.
Published: (2016-01-01)

Stable angina pectoris: population trends, diagnostics, secondary prevention, and antianginal therapy
by: R. G. Oganov, et al.
Published: (2006-02-01)

ANALYSIS OF COST STRUCTURE FOR PHARMACOTHERAPY OF PATIENTS WITH STABLE ANGINA (THE CASE OF CARDIOLOGY DEPARTMENT OF TVER REGIONAL CLINICAL HOSPITAL)
by: M. A. Demidova, et al.
Published: (2015-12-01)

Secondary prevention effectiveness in patients with stable angina
by: Rasim Kutlu, et al.
Published: (2010-08-01)

The First Results of the Evaluation of Long-Term Nicorandil Treatment Effect on the Probability of Cardiovascular Complications in Patients with Stable Coronary Artery Disease (Data of Observational NIKEA Study)
by: S. Yu. Martsevich, et al.
Published: (2019-07-01)

2020 Clinical practice guidelines for Stable coronary artery disease
by: . Russian Society of Cardiology (RSC)
Published: (2020-12-01)

Effort angina pharmacotherapy in ambulatory practice
by: E. V. Gosteva
Published: (2008-06-01)